Translational Science

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

We reveal The Medicine Maker 2021 Power List!

We find out the story behind the Baylor College of Medicine Center for Space Medicine.

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.